Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

According to the ministry, the scheme has facilitated the establishment of domestic manufacturing capabilities for a range of high-end medical devices that were earlier predominantly imported.

New Delhi: The Product Linked Incentive (PLI) scheme for medical devices has given a boost to local manufacturing of high-end medical technology devices, including MRI machines, CT Scanner and heart valves, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers said.

According to the ministry, production of 57 medical devices commenced under the scheme that were earlier predominantly imported. These include MRI machines, CT scanners, Cath Labs, Linear Accelerators, C-Arms, mammography machines, ultrasound systems, anaesthesia machines and heart valves.

The initiative has also attracted leading global manufacturers such as GE Healthcare, Siemens, Philips, Varex, Nipro and Omron and encouraged technology transfer and advanced manufacturing capabilities in India, the ministry added.

The PLI scheme with a total financial outlay of Rs 3,420 crore was launched in 2020 and provides a 5 per cent incentive on incremental sales of eligible medical devices manufactured in India for a period of five years.

It covers four broad segments, cancer care/radiotherapy medical devices; radiology and imaging devices; anaesthesia, cardio-respiratory and renal care devices; and implants, including implantable electronic devices, the ministry said.

  • Related Posts

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India Limited has set up its new corporate office in Mumbai, marking an extension of company’s presence in India, reinforcing its ambition to transforming care by unlocking the…

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Exports of drugs and pharmaceuticals from the country have reported a growth of around 4.9% during the first six months of the current fiscal year, at $16.13 billion, as compared…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested